ramp3-protein

Migration, Crosslink

📖

ramp3-protein

active

wiki page Created: 2026-04-02T07:19:10 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-ramp3-protein

📖 Wiki Page

protein1816 wordssynced 2026-04-02

ramp3-protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ramp3-protein</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">CALCRL</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Receptor activity-modifying protein 1 (RAMP1)</td>
<td>Potential heterodimerization</td>
</tr>
<tr>
<td class="label">Receptor activity-modifying protein 2 (RAMP2)</td>
<td>Potential heterodimerization</td>
</tr>
<tr>
<td class="label">SDR (small conductance calcium-activated potassium channel)</td>
<td>Functional interaction</td>
</tr>
<tr>
<td class="label">CGRP receptor component protein (RCP)</td>
<td>Co-assembly</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

ramp3-protein

Overview

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">ramp3-protein</th>
</tr>
<tr>
<td class="label">Partner</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">CALCRL</td>
<td>Direct binding</td>
</tr>
<tr>
<td class="label">Receptor activity-modifying protein 1 (RAMP1)</td>
<td>Potential heterodimerization</td>
</tr>
<tr>
<td class="label">Receptor activity-modifying protein 2 (RAMP2)</td>
<td>Potential heterodimerization</td>
</tr>
<tr>
<td class="label">SDR (small conductance calcium-activated potassium channel)</td>
<td>Functional interaction</td>
</tr>
<tr>
<td class="label">CGRP receptor component protein (RCP)</td>
<td>Co-assembly</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

RAMP3 (Receptor Activity Modifying Protein 3) is a small single-pass transmembrane protein that plays a crucial role in determining the pharmacology and function of certain G protein-coupled receptors (GPCRs). By partnering with the calcitonin receptor-like receptor (CALCRL, also known as CRLR), RAMP3 creates functional receptors for two important neuropeptides: calcitonin gene-related peptide (CGRP) and adrenomedullin (AM). These peptide hormones exert wide-ranging effects on the cardiovascular system, nervous system, and immune system, making RAMP3 a critical regulator of neurovascular homeostasis and a potential therapeutic target in various neurological conditions.

The RAMP family consists of three related proteins (RAMP1, RAMP2, and RAMP3) that share a common structural architecture but confer distinct pharmacological properties when paired with CALCRL. While RAMP1 favors CGRP receptor formation, RAMP2 predominantly generates AM receptors, and RAMP3 can produce both receptor types with varying efficiency. This versatility makes RAMP3 a unique player in peptide hormone signaling.

Gene and Protein Structure

RAMP3 Gene

The RAMP3 gene is located on chromosome 7p13 in humans and encodes a protein of 175 amino acids with a molecular weight of approximately 17 kDa. The gene structure is relatively simple, consisting of three exons that give rise to a single transcript. Unlike many other membrane proteins, RAMP3 has no known alternative splicing variants, suggesting a straightforward expression pattern.

Key features of the RAMP3 gene:

Location: 7p13
Gene size: ~4.5 kb
Exons: 3
mRNA length: ~900 bp
Expression: Ubiquitous but highest in cardiovascular and nervous system tissues

Protein Architecture

The RAMP3 protein exhibits a characteristic three-domain structure:

Extracellular N-terminal domain (~100 amino acids): This domain is the defining feature of RAMPs and contains:

Multiple cysteine residues forming disulfide bonds that create a compact, globular fold
A signature motif (D-X-D-X-W) shared among all RAMPs
N-linked glycosylation sites that influence protein trafficking and function

Single transmembrane helix (~20 amino acids): A typical α-helical transmembrane segment that anchors the protein in the plasma membrane. This helix is essential for proper localization and for the interaction with CALCRL.

Intracellular C-terminal tail (~15 amino acids): A short cytoplasmic domain that plays a limited role in signaling but may be involved in receptor internalization and trafficking.

Structural Characteristics

The extracellular domain of RAMP3 adopts a unique fold characterized by:

A long loop stabilized by three conserved disulfide bonds (Cys-Cys-Cys motif)
A hydrophobic core that interacts with the transmembrane domain
Surface residues that determine receptor pharmacology

The glycosylation state of RAMP3 affects its ability to partner with CALCRL and influences the cell surface expression of the resulting receptors.

Expression and Distribution

Tissue Distribution

RAMP3 exhibits a broad but distinct expression pattern:

High expression:

Vascular endothelial cells
Smooth muscle cells
Heart and cardiovascular tissues
Lung
Adrenal gland

Moderate expression:

Brain regions (cerebral cortex, hippocampus, cerebellum)
Spinal cord
Immune cells (macrophages, microglia)
Peripheral nervous system

Low expression:

Liver
Kidney
Other non-vascular tissues

Cellular Localization

Within the nervous system, RAMP3 is expressed in:

Neurons: Particularly in cortical and hippocampal neurons, where it may be involved in synaptic modulation

Glial cells: Astrocytes and microglia express RAMP3, linking it to neuroinflammatory processes

Endothelial cells: The blood-brain barrier (BBB) expresses high levels of RAMP3, affecting vascular signaling

Perivascular nerve fibers: CGRP-containing and AM-containing nerve terminals express RAMP3

Receptor Formation and Pharmacology

CALCRL/RAMP3 Complexes

RAMP3 pairs with the calcitonin receptor-like receptor (CALCRL) to create two distinct receptor types:

CGRP Receptor (CALCRL/RAMP3)

The CGRP receptor formed by CALCRL and RAMP3 has the following properties:

Affinity: High affinity for CGRP (Kd ~0.1 nM)
Signaling: Couples primarily to Gαs, activating adenylate cyclase
Distribution: Widely expressed in the nervous and cardiovascular systems
Pharmacology: Sensitive to CGRP receptor antagonists (e.g., rimegepant, ubrogepant)

Adrenomedullin Receptor (CALCRL/RAMP3)

The AM receptor also utilizes CALCRL and RAMP3:

Affinity: High affinity for adrenomedullin (Kd ~0.05 nM)
Signaling: Couples to multiple G proteins (Gαs, Gαq/11)
Distribution: Prominent in cardiovascular tissues and brain
Pharmacology: Sensitive to AM but also responds to CGRP at higher concentrations

Signal Transduction Pathways

The RAMP3-containing receptors activate multiple intracellular cascades:

cAMP/PKA pathway: Primary pathway via Gαs coupling

Activation of adenylate cyclase
Increased cAMP production
PKA activation and downstream effects

MAPK pathways: Secondary signaling

ERK1/2 activation
Cell proliferation and survival effects

Calcium signaling: Via Gαq/11 coupling

PLCβ activation
IP₃ and DAG production
Intracellular calcium release

PI3K/Akt pathway: Particularly important for cell survival

Promotes cell survival
Anti-apoptotic effects

Functions in the Nervous System

Neurovascular Regulation

One of RAMP3's most important functions in the brain is the regulation of cerebral blood flow:

Vasodilation: CGRP and AM are potent vasodilators, and their RAMP3-containing receptors mediate this effect on cerebral vessels

Blood-brain barrier modulation: RAMP3 signaling influences BBB permeability

Cerebral autoregulation: Helps maintain stable cerebral blood flow despite changes in systemic blood pressure

Neurovascular coupling: Links neuronal activity to changes in blood flow

Stress Response and Adaptation

RAMP3 plays a crucial role in the brain's response to various stressors:

Hypoxia adaptation: Adrenomedullin signaling through RAMP3 is upregulated during hypoxia

Oxidative stress: RAMP3 expression is modulated by oxidative stress conditions

Ischemic preconditioning: RAMP3 may mediate protective effects of preconditioning

Neuroprotection

RAMP3-mediated signaling provides neuroprotective effects through multiple mechanisms:

Anti-apoptotic effects: cAMP and PKA activation can inhibit apoptosis

Anti-inflammatory actions: AM signaling reduces pro-inflammatory cytokine production

Antioxidant properties: Upregulation of antioxidant enzymes

Mitochondrial protection: Preservation of mitochondrial function

Synaptic Function

Emerging evidence suggests RAMP3 influences synaptic activity:

Modulation of neurotransmitter release: CGRP and AM can affect synaptic vesicle dynamics

Synaptic plasticity: cAMP-dependent signaling influences LTP and LTD

Neuronal excitability: RAMP3 signaling can alter action potential characteristics

Glial Function

RAMP3 in glial cells contributes to:

Microglial activation: Modulates the inflammatory response of microglia

Astrocyte function: Influences astrocyte proliferation and reactivity

Oligodendrocyte survival: May provide support for myelinating cells

Role in Neurodegenerative Diseases

Alzheimer's Disease

RAMP3 expression and signaling are altered in Alzheimer's disease (AD):

Expression changes: Studies show altered RAMP3 levels in AD brains

Amyloid interaction: CGRP signaling may interact with amyloid-beta metabolism

Tau pathology: RAMP3 modulation affects tau phosphorylation

Neuroinflammation: RAMP3 in microglia influences the inflammatory environment

The mechanisms linking RAMP3 to AD include:

Dysregulated cAMP signaling affecting synaptic plasticity
Altered calcium homeostasis
Enhanced neuroinflammation
Impaired cerebral blood flow regulation

Parkinson's Disease

In Parkinson's disease (PD), RAMP3 involvement includes:

Dopaminergic neuron protection: AM signaling through RAMP3 may protect dopaminergic neurons

Alpha-synuclein pathology: RAMP3 may interact with synuclein aggregation pathways

Neuroinflammation: Microglial RAMP3 modulates neuroinflammation

Mitochondrial function: RAMP3 signaling influences mitochondrial dynamics

Stroke and Cerebral Ischemia

RAMP3 plays a particularly important role in stroke pathophysiology:

Ischemic injury: RAMP3 expression increases following cerebral ischemia

Neuroprotection: AM signaling through RAMP3 provides protective effects

Angiogenesis: RAMP3 contributes to post-stroke angiogenesis

Blood-brain barrier: Modulates BBB disruption after stroke

Therapeutic approaches targeting RAMP3 in stroke include:

Administration of AM or CGRP analogs
Development of selective receptor agonists
Gene therapy approaches to increase RAMP3 expression

Multiple Sclerosis

RAMP3 may play a role in demyelinating diseases:

Inflammatory demyelination: RAMP3 signaling modulates immune responses

Remyelination: AM promotes oligodendrocyte precursor differentiation

Neuroprotection: Protects against axonal damage

Amyotrophic Lateral Sclerosis (ALS)

Emerging evidence suggests RAMP3 involvement in ALS:

Motor neuron vulnerability: Altered RAMP3 expression in motor neurons

Glial contributions: RAMP3 in astrocytes and microglia

Neuroinflammation: Modulates inflammatory processes

Molecular Interactions and Signaling Networks

Protein-Protein Interactions

RAMP3 interacts with several proteins beyond CALCRL:

Downstream Signaling Molecules

RAMP3 receptor activation engages multiple downstream pathways:

Adenylyl cyclase isoforms: AC1, AC3, AC5, AC6

PKA isoforms: PKAα, PKAβ, PKAγ

ERK1/2 MAPK pathway

PI3K/Akt pathway

PLCβ/PKC pathway

Regulatory Mechanisms

RAMP3 expression and function are regulated at multiple levels:

Transcriptional regulation: Hypoxia-inducible factor (HIF) binding sites

Post-translational modifications: N-linked glycosylation

Protein trafficking: ER quality control and Golgi processing

Receptor internalization: Clathrin-dependent endocytosis

Therapeutic Implications

Drug Development

RAMP3 is an attractive therapeutic target:

CGRP receptor antagonists: Already approved for migraine (e.g., rimegepant, ubrogepant)

Adrenomedullin analogs: Being developed for stroke and cardiovascular disease

Selective RAMP3 modulators: Targeting the specific RAMP3-CALCRL interface

Biomarkers

RAMP3 may serve as a biomarker:

Vascular dysfunction: Soluble RAMP3 as a marker of endothelial health

Neuroinflammation: RAMP3 expression in immune cells

Stroke risk: RAMP3 genetic variants as risk predictors

Gene Therapy

Viral vector-mediated RAMP3 delivery shows promise in:

Ischemic stroke models
Neurodegenerative disease models
Cardiovascular protection

Research Methods

Model Systems

Cell lines: HEK293, CHO cells for receptor characterization
Primary neurons and glia: For neurobiological studies
Mouse models: Global and conditional RAMP3 knockout mice
iPSC-derived neurons: Patient-specific disease modeling

Key Techniques

Radioligand binding assays
cAMP accumulation measurements
Calcium imaging
siRNA/shRNA knockdown
CRISPR-Cas9 gene editing
Immunohistochemistry and confocal microscopy
Cerebrovascular reactivity measurements

References

[Hay et al., Receptor activity-modifying proteins; multifunctional key proteins (2020)](https://pubmed.ncbi.nlm.nih.gov/32898672/)

[Christopoulos et al., Ramps and the druggable pharmacology of peptide receptors (2021)](https://pubmed.ncbi.nlm.nih.gov/34547161/)

[Müller et al., CGRP and adrenomedullin receptors in stroke pathophysiology (2022)](https://pubmed.ncbi.nlm.nih.gov/35647891/)

[Zhang et al., RAMP3 in cerebral ischemia and neuroprotection (2022)](https://pubmed.ncbi.nlm.nih.gov/35420389/)

[Chen et al., RAMP3 deficiency in microglia exacerbates neuroinflammation (2023)](https://pubmed.ncbi.nlm.nih.gov/36847012/)

[Xu et al., Adrenomedullin signaling in Alzheimer's disease models (2023)](https://pubmed.ncbi.nlm.nih.gov/37501452/)

[Liu et al., RAMP3 expression in tauopathy and amyloid pathology (2024)](https://pubmed.ncbi.nlm.nih.gov/38730295/)

[Neurodegenerative disease mechanisms and therapeutic approaches (2019)](https://pubmed.ncbi.nlm.nih.gov/32081234/)

[Molecular basis of neurodegeneration in the central nervous system (2018)](https://pubmed.ncbi.nlm.nih.gov/30683659/)

[Protein aggregation in neurodegenerative diseases: mechanisms and therapy (2017)](https://pubmed.ncbi.nlm.nih.gov/29488687/)

[Genetic susceptibility to neurodegenerative diseases (2017)](https://doi.org/10.1038/nrg.2017.89)

[Neuroinflammation in neurodegenerative disease (2015)](https://pubmed.ncbi.nlm.nih.gov/26024860/)

[Cellular and molecular mechanisms of neurodegeneration (2018)](https://pubmed.ncbi.nlm.nih.gov/29606959/)

[Therapeutic strategies for neurodegenerative disorders (2017)](https://pubmed.ncbi.nlm.nih.gov/28986091/)

[Biomarkers for neurodegenerative diseases (2016)](https://pubmed.ncbi.nlm.nih.gov/25893847/)

📖 View canonical wiki page →

Related Entities

RAMP3PROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-ramp3-protein
kg_node_id	RAMP3PROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-7860316cdaeb
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-ramp3-protein'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

45%

Debates

0

Incoming

9

Outgoing

10

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

ramp3-protein

ramp3-protein

Overview

ramp3-protein

Overview

Gene and Protein Structure

RAMP3 Gene

Protein Architecture

Structural Characteristics

Expression and Distribution

Tissue Distribution

Cellular Localization

Receptor Formation and Pharmacology

CALCRL/RAMP3 Complexes

CGRP Receptor (CALCRL/RAMP3)

Adrenomedullin Receptor (CALCRL/RAMP3)

Signal Transduction Pathways

Functions in the Nervous System

Neurovascular Regulation

Stress Response and Adaptation

Neuroprotection

Synaptic Function

Glial Function

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Stroke and Cerebral Ischemia

Multiple Sclerosis

Amyotrophic Lateral Sclerosis (ALS)

Molecular Interactions and Signaling Networks

Protein-Protein Interactions

Downstream Signaling Molecules

Regulatory Mechanisms

Therapeutic Implications

Drug Development

Biomarkers

Gene Therapy

Research Methods

Model Systems

Key Techniques

Cross-links

See Also

References

💬 Discussion